US Broker Ratings

Indivior Pharmaceuticals, Inc. (INDV) Stock Analysis: A 51% Potential Upside Awaits Investors

Investors seeking opportunities in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, should not overlook Indivior Pharmaceuticals, Inc. (NASDAQ: INDV). With a..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: A Promising 52.68% Upside Potential Awaits Investors

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), a promising player in the biotechnology sector focusing on dermatological treatments, presents a compelling case for investors seeking growth opportunities. With..

Ocular Therapeutix, Inc. (OCUL): Analyst Ratings Suggest 203% Upside Potential in Biotech Sector

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a player in the biotechnology sector, has been making waves with its innovative approach to treating retinal diseases and other eye..

Amphastar Pharmaceuticals (AMPH) Stock Analysis: A Potential 49% Upside in Healthcare

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a key player in the drug manufacturing sector, presents an intriguing opportunity for investors looking to capitalize on the healthcare industry’s..

Surgery Partners, Inc. (SGRY) Stock Analysis: Exploring a 56% Upside Potential Amid Market Challenges

Surgery Partners, Inc. (NASDAQ: SGRY), a key player in the healthcare sector specializing in medical care facilities, presents a complex yet intriguing case for individual investors...

AdaptHealth Corp. (AHCO) Stock Analysis: Is a 23% Upside Within Reach?

AdaptHealth Corp. (NASDAQ: AHCO), a key player in the healthcare sector specializing in medical devices, is drawing investor attention with a promising potential upside of 23.56%...

CONMED Corporation (CNMD) Stock Analysis: Navigating a 26.7% Potential Upside in the Medical Devices Sector

As individual investors eye opportunities within the healthcare sector, CONMED Corporation (NASDAQ: CNMD) stands out with a compelling 26.7% potential upside. This medical technology company, headquartered..

Mesoblast Limited (MESO) Stock Analysis: Exploring a 139% Potential Upside in Biotech

Mesoblast Limited (NASDAQ: MESO), an Australian biotechnology company, is gaining attention within the healthcare sector due to its regenerative medicine products and significant growth potential. With..

Ultragenyx Pharmaceutical Inc. (RARE): Analyst Consensus Reveals 148% Potential Upside Amidst Robust Revenue Growth

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) stands out in the healthcare sector as a pioneering biopharmaceutical company focused on the development of novel treatments for rare and..

Arrowhead Pharmaceuticals (ARWR): Investor Outlook Reveals Promising 41.82% Upside Potential

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) has captured the attention of investors with its impressive growth trajectory and a robust pipeline of innovative therapeutic solutions. As a..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Exploring a 33% Potential Upside

Investors eyeing opportunities in the healthcare sector might want to take a closer look at U.S. Physical Therapy, Inc. (NYSE: USPH), a company that stands out..

10x Genomics, Inc. (TXG) Stock Analysis: Evaluating Its 20.69% Potential Upside Amid Innovative Growth

10x Genomics, Inc. (NASDAQ: TXG) stands as a compelling player in the healthcare sector, specifically within the health information services industry. With a market capitalization of..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Biotechnology Innovator with 34.88% Potential Upside

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) stands at an intriguing juncture for investors, especially given its position in the rapidly evolving biotechnology sector. With a market capitalization..

Galapagos NV (GLPG) Stock Analysis: Evaluating Growth Potential Amidst Biotech Volatility

For investors navigating the ever-evolving landscape of biotechnology stocks, Galapagos NV (NASDAQ: GLPG) presents a unique case study. Headquartered in Mechelen, Belgium, Galapagos operates within the..

NewAmsterdam Pharma (NAMS) Stock Analysis: A Biotech Contender with 60.79% Upside Potential

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a Netherlands-based biotechnology firm, has emerged as a notable name in the healthcare sector, particularly with its focus on cardiometabolic..

Guardian Pharmacy Services, Inc. (GRDN) Stock Analysis: A Healthcare Player with a 16.91% Upside Potential

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN) is making waves in the healthcare sector, particularly in the niche market of long-term care facilities (LTCFs) across the United..

SS Innovations International (SSII) Performance Highlights: Exploring 79.10% Revenue Growth and Strategic Positioning in Medical Devices

SS Innovations International, Inc. (SSII), a trailblazer in the medical devices sector, is making waves in the healthcare industry with its cutting-edge surgical robotics. Headquartered in..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Is a 110% Upside Within Reach?

Dyne Therapeutics, Inc. (NASDAQ: DYN) is currently capturing the attention of investors, with a potential upside of 110.63% according to analyst ratings. This clinical-stage biotechnology company,..

Protagonist Therapeutics (PTGX) Stock Analysis: Exploring a Promising 11.46% Upside in Biotech

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) has been capturing investor attention with its strategic focus on innovative therapies within the biotechnology sector. The company, headquartered in Newark,..

ICU Medical, Inc. (ICUI): Investor Outlook Reveals Strong Potential Upside of 43.88%

ICU Medical, Inc. (NASDAQ: ICUI) stands as a pivotal player in the healthcare sector, specializing in the development and sale of medical instruments and supplies. With..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds